BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 88 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $289,000 | -44.6% | 5,397 | -38.3% | 0.00% | -33.3% |
| Q2 2019 | $522,000 | +166.3% | 8,743 | +178.2% | 0.00% | +200.0% |
| Q1 2019 | $196,000 | +151.3% | 3,143 | +144.8% | 0.00% | – |
| Q4 2018 | $78,000 | +4.0% | 1,284 | 0.0% | 0.00% | – |
| Q3 2018 | $75,000 | +29.3% | 1,284 | 0.0% | 0.00% | – |
| Q2 2018 | $58,000 | +1.8% | 1,284 | 0.0% | 0.00% | – |
| Q1 2018 | $57,000 | -52.9% | 1,284 | -53.9% | 0.00% | -100.0% |
| Q4 2017 | $121,000 | -29.2% | 2,784 | -24.2% | 0.00% | 0.0% |
| Q3 2017 | $171,000 | -53.0% | 3,674 | -50.0% | 0.00% | 0.0% |
| Q2 2017 | $364,000 | +81.1% | 7,348 | +100.0% | 0.00% | 0.0% |
| Q1 2017 | $201,000 | +25.6% | 3,674 | +16.2% | 0.00% | 0.0% |
| Q4 2016 | $160,000 | +247.8% | 3,161 | +139.3% | 0.00% | – |
| Q1 2016 | $46,000 | – | 1,321 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 73,649 | $3,646,000 | 2.32% |
| Stonepine Capital Management, LLC | 59,878 | $2,965,000 | 1.60% |
| NORTHPOINTE CAPITAL LLC | 109,644 | $5,428,000 | 0.57% |
| Elk Creek Partners, LLC | 145,406 | $7,199,000 | 0.47% |
| TFS CAPITAL LLC | 18,208 | $901,000 | 0.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 161,671 | $8,004,000 | 0.35% |
| Ativo Capital Management LLC | 19,592 | $970,000 | 0.26% |
| Matarin Capital Management, LLC | 57,034 | $2,823,753,000 | 0.26% |
| ISTHMUS PARTNERS, LLC | 16,505 | $817,000 | 0.24% |
| Stanley-Laman Group, Ltd. | 12,546 | $621,000 | 0.17% |